Incidental Findings at Surgery-Part 1

Current Problems in Surgery

Volumn 45, Issue 5, 2008, Pages 325-374

  Schaberg Jr , Frank J ^a   Doyle, M B Majella ^b   Chapman, William C ^b   Vollmer Jr , Charles M ^c   Zalieckas, Jill M ^d   Birkett, Desmond H ^d   Miner, Thomas J ^a   Mazzaglia, Peter J ^a  

^a BROWN UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; 6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL I 131; FLUORODEOXYGLUCOSE F 18; IMMUNOSUPPRESSIVE AGENT; PENTETREOTIDE IN 111;

ADRENAL BIOPSY; ADRENAL INCIDENTALOMA; ADRENALECTOMY; AORTA ANEURYSM; ARTICLE; ARTIFICIAL EMBOLISM; ASPIRATION; BARIATRIC SURGERY; BILE DUCT CARCINOMA; CANCER SURVIVAL; CHOLECYSTECTOMY; CHRONIC LIVER DISEASE; COLONOSCOPY; COLORECTAL CANCER; CONSERVATIVE TREATMENT; CYSTADENOCARCINOMA; CYSTADENOMA; CYSTIC FIBROSIS; DIABETES MELLITUS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GALLSTONE; GASTROINTESTINAL SURGERY; GASTROSCOPY; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENTAL FINDING; INCIDENTALOMA; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LAPAROSCOPIC SURGERY; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER HEMANGIOMA; LIVER POLYCYSTIC DISEASE; LIVER RESECTION; LIVER TRANSPLANTATION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; METASTASIS POTENTIAL; MORBIDITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN TRANSPLANTATION; PANCREAS RESECTION; PANCREAS TUMOR; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; RECURRENT DISEASE; RISK FACTOR; SCLEROTHERAPY; SICKLE CELL ANEMIA; SOLID TUMOR; SURGERY; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION;

ADRENAL GLAND NEOPLASMS; AORTIC ANEURYSM, ABDOMINAL; GALLSTONES; HUMANS; INCIDENTAL FINDINGS; LIVER NEOPLASMS; NEOPLASMS; PANCREATIC NEOPLASMS; PERIOPERATIVE CARE;

EID: 41549141719     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2008.01.004     Document Type: Article

References (91)

1. Choi B. The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 39 (2005) 401-412
2. Belghiti J., Vilgrain V., and Paradis V. Benign liver lesions. In: Blumgart L., Belghiti J., Jarnagin W., Dematteo R., Chapman W., Buchler M., et al. (Eds). Surgery of Liver, Billiary Tract and Pancreas. 4th ed. (2007), Saunders Elsevier Inc, Philadelphia 917-926 Vol 1
3. Arnold H.L., and Harrison S.A. New advances in evaluation and management of patients with polycystic liver disease. Am J Gastroenterol 100 (2005) 2569-2582
4. Wanless I.R. Benign liver tumors. Clin Liver Dis 6 (2002) 513-526
5. Vogt D.P., Henderson J.M., and Chmielewski E. Cystadenoma and cystadenocarcinoma of the liver: a single center experience. J Am Coll Surg 200 (2005) 727-733
6. Hochwald S.N., and Blumgart L.N. Giant hepatic hemangioma with Kasabach-Merritt syndrome: is the appropriate treatment enucleation or liver transplantation?. HPB Surg 11 (2000) 413-419
7. Herman P., Costa M.L., Machado M.A., Pugliese V., D'Albuquerque L.A., Machado M.C., et al. Management of hepatic hemangiomas: a 14-year experience. J Gastrointest Surg 9 (2005) 853-859
8. Yoon S., Charny C., Fong Y., Jarnagin W., Schwartz L., Blumgart L., et al. Diagnosis, management, and outcomes of 115 patient with hepatic hemangioma. J Am Coll Surg 197 (2003) 392-402
9. Herman P., Pugliese V., Machado M., Montagnini A., Salem M., Bacchella T., et al. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg 24 (2000) 372-376
10. Gordon S.C., Reddy K.R., Livingstone A.S., Jeffers L.J., and Schiff E.R. Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma. Ann Intern Med 105 (1986) 547-551
11. Chiche L., Dao T., Salamé E., Galais M.P., Bouvard N., Schmutz G., et al. Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg 231 (2000) 74-81
12. Al-Mukhaizeem K., Rosenberg A., and Sherker A. Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders. Am J Hematol 75 (2004) 225-230
13. Wei S., Huang G., Chen C., Sheu J., Tsang Y., Hsu H., et al. Bile duct hamartomas: a report of two cases. J Clin Gastroenterol 25 (1997) 608-611
14. Yeh C.N., Chen M.F., Hung C.F., Chen T.C., and Chao T.C. Angiomyolipoma of the liver. J Surg Oncol 77 (2001) 195-200
15. Brunt E. Pathology of fatty liver disease. Mod Pathol 20 (2007) S40-S48
16. Dixon J. Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis. Clin Liver Dis 11 (2007) 141-154
17. Riley P., O'Donohue J., and Crook M. A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease. J Clin Pathol 10 (2007) 1136
18. Sass D., Chang P., and Chopra K. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci 50 (2005) 171-180
19. Shoelson S., Herrero L., and Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 132 (2007) 2169-2180
20. Befeler A.S., Palmer D.E., Hoffman M., Longo W., Solomon H., and Di Bisceglie A.M. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. Arch Surg 140 (2005) 650-654 discussion 655
21. Franzetta M., Raimondo D., Giammanco M., Di Trapani B., Passariello P., Sammartano A., et al. Prognostic factors of cirrhotic patients in extra-hepatic surgery. Minerva Chir 58 (2003) 541-544
22. Huo T.I., Lin H.C., Wu J.C., Lee F.Y., Hou M.C., Lee P.C., et al. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl 12 (2006) 65-71
23. Northup P.G., Wanamaker R.C., Lee V.D., Adams R.B., and Berg C.L. Model for end-stage liver disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg 242 (2005) 244-251
24. Ramírez G.A., and Arizpe B.D. Surgical risk and complications after major surgery in patients with cirrhosis. Rev Invest Clin 42 (1990) 7-13
25. Teh S.H., Nagorney D.M., Stevens S.R., Offord K.P., Therneau T.M., Plevak D.J., et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 132 (2007) 1261-1269
26. Heuman D.M., Abou-Assi S.G., Habib A., Williams L.M., Stravitz R.T., Sanyal A.J., et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 40 (2004) 802-810
27. Kostiuk T.S. Observation of pancreatic incidentaloma. Klin Khir 9 (2001) 62-63
28. Winter J.M., Cameron J.L., Lillemoe K.D., Campbell K.A., Chang D., Riall T.S., et al. Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis. Ann Surg 243 (2006) 673-683
29. Tanaka M., Chari S., Adsay V., Fernandez-del Castillo C., Falconi M., Shimizu M., et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6 (2006) 17-32
30. Strasberg S.M., Middleton W.D., Teefey S.A., McNevin M.S., and Drebin J.A. Management of diagnostic dilemmas of the pancreas by ultrasonographically guided laparoscopic biopsy. Surgery 126 (1999) 736-741
31. Clinical Care Guideline: Cystic Neoplasms of the Pancreas. Society for Surgery of the Alimentary Tract (SSAT) Web site. Available from: http://www.ssat.com/cgi-bin/guidelines.cgi.
32. Brugge W.R., Lauwers G.Y., Sahani D., Fernandez-del Castillo C., and Warshaw A.L. Cystic neoplasms of the pancreas. N Engl J Med 351 (2004) 1218-1226
33. Fernandez-del Castillo C., Targarona J., Thayer S.P., Rattner D.W., Brugge W.R., and Warshaw A.L. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg 138 (2003) 427-434
34. Waaij L.A., van Dullerman H.M., and Porte R.J. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc 62 (2005) 382-389
35. Gallstones and Laparoscopic Cholecystectomy. NIH Consensus Statement Online. 1992 Sep 14-16;10(3):1-20. http://consensus.nih.gov/1992/1992GallstonesLaparoscopy090html.htm Accessed March 12, 2008
36. Ahrendt S.A., and Pitt H.A. Biliary Tract. In: Townsend C.M., Beauchamp R.D., Evers B.M., and Mattox K.L. (Eds). Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 17th ed. (2004), Elsevier, Philadelphia 1605-1609
37. Ransohoff D.F., and Gracie W.A. Treatment of gallstones. Ann Int Med 119 (1993) 606-619
38. Gracie W.A., and Ransohoff D.F. The natural history of gallstones: the innocent gallstone is not a myth. N Engl J Med 309 (1982) 78-80
39. Friedman G.D., Raviola C.A., and Fireman B. Prognosis of gallstones with mild or no symptoms: 25 years of follow-up in a health maintenance organization. J Clin Epidemiol 42 (1989) 127-136
40. Zubler J., Markowski G., Yale S., Graham R., and Rosenthal T.C. Natural history of asymptomatic gallstones in family practice office practices. Arch Fam Med 7 (1998) 230-233
41. Abou-Saif A., and Al-Kawas F.H. Complications of gallstone disease: Mirizzi syndrome, cholecystocholedochal fistula and gallstone ileus. Am J Gastroenterol 97 (2002) 249-254
42. Sakorafas G.H., Milingos D., and Peros G. Asymptomatic cholelithiasis: is cholecystectomy really needed?. Dig Dis Sci 52 (2007) 1313-1325
43. Walsh D.B., Eckhauser F.E., Ramsburgh S.R., and Burney R.B. Risk associated with diabetes mellitus in patients undergoing gallbladder surgery. Surg 91 (1982) 254-257
44. Hjortrup A., Sorensen C., Dyremose E., Hjortso N.C., and Kehlet H. Influence of diabetes mellitus on operative risk. Br J Surg 72 (1985) 783-785
45. Hjortrup A., Sorensen C., Dyremose E., and Kehlet H. Morbidity in diabetic and nondiabetic patients after abdominal surgery. Acta Chir Scand 151 (1985) 445-447
46. Hickman M.S., Schwesinger W.H., and Page C.P. Acute cholecystitis in the diabetic. Arch Surg 123 (1988) 409-411
47. Kao L.S., Kuhr C.S., and Flum D.R. Should cholecystectomy be performed for asymptomatic cholelithiasis in transplant patients?. J Am Coll Surg 197 (2003) 302-312
48. Kao L.S., Flowers C., and Flum D.R. Prophylactic cholecystectomy in transplant patients: a decision analysis. J Gastrointest Surg 9 (2005) 965-972
49. Richardson W.S., Surowiec W.J., Carter K.M., Howell T.P., Mehra M.R., and Bowen J.C. Gallstone disease in heart transplant recipients. Ann Surg 237 (2003) 273-276
50. Melvin W.S., Meier D.J., Elkhammas E.A., Bumgardner G.L., Davies E.A., Henry M.L., et al. Prophylactic cholecystectomy is not indicated following renal transplantation. Am J Surg 175 (1998) 317-319
51. Jackson T., Treleaven D., Arlen D., Lambert K., and Birch D.W. Management of asymptomatic cholelithiasis for patient waiting renal transplantation. Surg Endosc 19 (2005) 510-513
52. Ottinger L.W. Acute cholecystitis as a postoperative complication. Ann Surg 184 (1976) 162-165
53. Heydorn W.H., and Moncrief Jr. W.H. Simultaneous reconstruction of the abdominal aorta and cholecystectomy-a peer review perspective. West J Med 157 (1992) 569-571
54. Juhasz E.S., Wolff B.G., Meagher A.P., Kluiber R.M., Weaver A.L., and van Heerden J.A. Incidental cholecystectomy during colorectal surgery. Ann Surg 219 (1994) 467-474
55. Klaus A., Hinder R.A., Swain J., and Achem S.R. Incidental cholecystectomy during laparoscopic antireflux surgery. Am Surg 68 (2002) 619-623
56. Schreiber H., Macon W.L., and Pories W.J. Incidental cholecystectomy during major abdominal surgery in the elderly. Am J Surg 135 (1978) 196-198
57. Kovalcik P.J., Burrell M.J., and Old W.L. Cholecystectomy concomitant with other intraabdominal operations. Assessment of risk. Arch Surg 118 (1983) 1059-1062
58. Silva M.A., and Wong T. Gallstones in chronic liver disease. J Gastrointest Surg 9 (2005) 739-746
59. Puggioni A, Wong LL. A metaanalysis of laparoscopic cholecystectomy in patients with cirrhosis. J Am Coll Surg 203;197:921-6.
60. Orozco H., Takahashi T., Mercado M.A., Prado E., and Borunda D. Long-term evolution of asymptomatic cholelithiasis diagnosed during abdominal operations for variceal bleeding in patients with cirrhosis. Am J Surg 168 (1994) 232-234
61. Fobi M., Lee H., Igwe D., Felahy B., James E., Stanczyk M., and Fobi N. Prophylactic cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg 12 (2002) 350-353
62. Amaral J., and Thompson W. Gallbladder disease in the morbidly obese. Am J Surg 149 (1985) 551-557
63. Schmidt J., Hocking M., Rout W., and Woodward E. The case for prophylactic cholecystectomy concomitant with gastric restriction for morbid obesity. Am Surg 54 (1988) 269-272
64. Wudel L., Wright J., Debelak J., Allos T., Shyr Y., and Chapman W.C. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res 102 1 (2002) 50-56
65. O'Brien P.E., and Dixon J.B. A rational approach to cholelithiasis in bariatric surgery. Arch Surg 138 (2003) 908-912
66. Swartz D.E., and Felix E.L. Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbid obese patients?. Surg Obes Relat Dis 6 (2005) 555-560
67. Shiffman M., Sugerman H., Kellum J., Brewer W., and Moore E. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 86 (1991) 1000-1005
68. Sarnaik S., Slovis T.L., Corbett D.P., Emami A., and Whitten C.F. Incidence of cholelithiasis in sickle cell anemia using the ultrasonic gray-scale technique. J Pediatr 96 (1980) 1005-1008
69. Schnog J.B., Duits A.J., Muskiet F.A., ten Cate H., Rojer R.A., and Brandjes D.P. Sickle cell disease: a general overview. Neth J Med 62 (2004) 364-374
70. Curro G., Meo A., Ippolito D., Pusiol A., and Cucinotta E. Asymptomatic cholelithiasis in children with sickle cell disease. Ann Surg 245 (2007) 126-129
71. Bond L.R., Hatty S.R., Horn M.E., Dick M., Meire H.B., and Bellingham A.J. Gall stones in sickle cell disease in the United Kingdom. BMJ 295 (1987) 234-236
72. Jawad A.J., Kurban K., el-Bakry A., al-Rabeeah A., Seraj M., and Ammar A. Laparoscopic cholecystectomy for cholelithiasis during infancy and childhood: cost analysis and review of current indications. World J Surg 22 (1998) 69-73
73. Miltenburg D.M., Schaffer R., Breslin T., and Brandt M.L. Changing indications for pediatric cholecystectomy. Pediatrics 105 (2000) 1250-1253
74. Ware R., Filston H.C., Schultz W.H., and Kinney T.R. Elective cholecystectomy in children with sickle hemoglobinopathies. Successful outcome using a preoperative transfusion regimen. Ann Surg 208 (1988) 17-22
75. Rambo W.M., and Reines H.D. Elective cholecystectomy for the patient with sickle cell disease and asymptomatic cholelithiasis. Am Surg 52 (1986) 205-207
76. Seguier-Lipszyc E., de Lagausie P., Benkerrou M., Di Napoli S., and Aigrain Y. Elective laparoscopic cholecystectomy. Surg Endosc 15 (2001) 301-304
77. Grumbach M.M., Biller B.M., Braunstein G.D., Campbell K.K., Carney J.A., Godley P.A., et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 138 (2003) 424-429
78. Young Jr. W.F. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 356 6 (2007) 601-610
79. Mansmann G., Lau J., Balk E., Rothberg M., Miyachi Y., Bornstein S.R., et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25 (2004) 309-340
80. Brunt L.M., and Moley J.F. Adrenal incidentaloma. World J Surg 25 (2001) 905-913
81. Young Jr. W.F. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29 (2000) 159-185 x
82. Dackiw A.P., Lee J.E., Gagel R.F., Evans D.B., et al. Adrenal cortical carcinoma. World J Surg 25 (2001) 914-926
83. Castillo O., Cortés O., Kerkebe M., Pinto I., Arellano L., and Contreras M. [Laparoscopic surgery in the treatment of adrenal pathology: experience with 200 cases]. Actas Urol Esp 30 (2006) 926-932
84. Sturgeon C., and Kebebew E. Laparoscopic adrenalectomy for malignancy. Surg Clin North Am 84 (2004) 755-774
85. Heinz-Peer G., Memarsadeghi M., and Niederle B. Imaging of adrenal masses. Curr Opin Urol 17 1 (2007) 32-38
86. Korobkin M., Francis I.R., Kloos R.T., and Dunnick N.R. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol 166 (1996) 531-536
87. Shen W.T., Sturgeon C., and Duh Q.Y. From incidentaloma to adrenocortical carcinoma: the surgical management of adrenal tumors. J Surg Oncol 89 (2005) 186-192
88. Thompson G.B., and Young Jr. W.F. Adrenal incidentaloma. Curr Opin Oncol 15 (2003) 84-90
89. Casola G., Nicolet V., van Sonnenberg E., Withers C., Bretagnolle M., Saba R.M., et al. Unsuspected pheochromocytoma: risk of blood-pressure alterations during percutaneous adrenal biopsy. Radiology 159 (1986) 733-735
90. Herrera M.F., Grant C.S., van Heerden J.A., Sheedy P.F., and Ilstrup D.M. Incidentally discovered adrenal tumors: an institutional perspective. Surgery 110 (1991) 1014-1021
91. Barzon L., Scaroni C., Sonino N., Fallo F., Paoletta A., and Boscaro M. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 84 (1999) 520-526